Where Things Stand
The FY2026 appropriations law enacted in November 2025 rewrote the federal definition of hemp. When the change takes effect, products containing more than 0.4 milligrams of total THC per container — a threshold most hemp-derived THC beverages, gummies and vapes exceed — lose their status as federally legal hemp, and cannabinoids synthesized from hemp-derived CBD are excluded from the definition entirely. This replaces the 2018 Farm Bill's 0.3% delta-9 THC dry-weight standard as the operative federal line for consumable hemp products, per Akerman's client alert.
Congress has moved the effective date once: the stopgap funding law H.R. 6500, signed September 3, 2026, pushed the main restrictions from November 12 to December 11, 2026 (Forbes). Akerman notes the delay applies to non-synthetic cannabinoids; provisions on synthetic cannabinoids remain on the original November 2026 timeline. Whether Congress delays again, amends the definition, or lets it take effect is the open question the industry is watching.
Timeline
-
November 2025 — Enacted
Appropriations law redefines federal hemp
The FY2026 appropriations package signed in November 2025 amends the hemp definition to exclude consumable products above 0.4 mg total THC per container and cannabinoids synthesized from hemp-derived CBD, with a one-year runway before the change takes effect.
-
September 3, 2026 — Signed
H.R. 6500 delays the main restrictions one month
The Continuing Appropriations and Extensions Act, 2027 moves the effective date for non-synthetic cannabinoid restrictions from November 12 to December 11, 2026 (Forbes; Akerman).
-
November 12, 2026 — Upcoming
Synthetic-cannabinoid provisions take effect
Per Akerman's reading of H.R. 6500, the delay covers non-synthetic cannabinoids only; synthetic cannabinoids remain subject to the original November 2026 timeline.
-
December 11, 2026 — Upcoming
The new hemp definition takes effect
Absent further congressional action, products above 0.4 mg total THC per container stop qualifying as federally legal hemp on this date. State law continues to govern separately — several states restrict these products earlier or more tightly than the federal timeline.
Dates reflect enacted law as reported by the linked sources as of the last-updated date above; pending bills and future continuing resolutions can move them. This page tracks the federal definition — state rules (caps, bans, licensing) apply on top of it and are covered in the state-by-state index.
What It Means for Beverage Businesses
- Producers and brands: hemp-THC beverages above 0.4 mg total THC per container lose their federal hemp status on December 11, 2026 — reformulation, state-licensed cannabis channels, or exit become the options in scope-affected markets.
- Distributors: inventory and contract exposure turns on the effective date and on each state's own rules; the federal change does not preempt states that already regulate or ban these products.
- Retailers: shelf decisions after December 11 depend on how enforcement agencies treat existing stock and on state law — several states have their own caps (for example, Virginia's 2 mg-per-package limit, in effect since August 2026) that bind regardless of the federal date.
Federal Hemp Coverage from the Daily Brief
Every item below links to its original source; the edition link opens that day's full brief.
DEA defers on adding GAO report to rescheduling record but opposes a new round of briefing
In the paused marijuana rescheduling hearing, DEA told Chief Administrative Law Judge Derek Julius it defers to him on whether a Government Accountability Office report — which found DEA and FDA lack written procedures for scheduling evaluations — should enter the record, while opposing opponents' request for added briefing; DEA said the report ident…
North Carolina’s $3 billion hemp industry prepares for the federal THC limits
The federal hemp rules Congress enacted in 2025 arrive in two steps: on November 12, products containing cannabinoids the cannabis plant cannot naturally produce fall outside the federal hemp definition, and on December 11 only hemp products with no more than 0.4 mg of total THC per container remain lawful. North Carolina’s hemp industry — roughly $3 bill…
Consumer group asks Congress to let the Dec. 11 hemp-THC deadline take effect
The National Consumers League said Congress "should do nothing to alter the closure of the hemp loophole," asking lawmakers to leave the December 11, 2026 effective date in place until what it called a robust regulatory regime for hemp-derived products is established, citing poison-control and emergency-department reports. The ask is the opposit…
Marijuana Policy Project asks Congress to halt the hemp THC ban and adopt a regulatory framework
The Marijuana Policy Project asked supporters to urge members of Congress to halt the scheduled federal ban on hemp THC products and replace it with a regulatory system including a 21-and-over age limit and testing, labeling and potency standards, writing that “creating a framework for regulations is the only viable path forward.” Several bills remain pen…
Justice Department and challengers propose briefing timeline in marijuana rescheduling appeal
The federal government and the parties challenging the administration's move of state-licensed medical marijuana products to Schedule III filed a joint proposed briefing schedule Friday in the U.S. Court of Appeals for the D.C. Circuit, which is weighing three consolidated lawsuits brought by Smart Approaches to Marijuana and the National Drug and Al…
Rep. Mast calls for ‘across-the-board’ review of federal drug scheduling
Rep. Brian Mast (R-FL), a co-chair of the Congressional Cannabis Caucus, said the administration's cannabis rescheduling should expand into an examination of scheduling for other controlled substances, naming cannabis, hemp and psilocybin among categories to review. A recent Government Accountability Office report found the DEA and FDA lack formal po…
State regulators say DEA has not answered their marijuana rescheduling questions
State cannabis regulators from Georgia, Vermont and California said the DEA has not provided implementation guidance on the federal move of state-regulated medical marijuana products to Schedule III, with Vermont Cannabis Control Board chair James Pepper saying a list of questions sent by a state regulators' association received “radio silence.” Cali…
DEA denies MedPharm's bulk marijuana manufacturing registration, citing unregistered production
In a decision published October 7 and effective November 6, the DEA denied Denver-based MedPharm Research LLC's application to register as a bulk Schedule I marijuana manufacturer, finding that affiliated companies under the same CEO had manufactured marijuana for the recreational market without DEA registration. The order notes the denial does not b…
DEA opens federal registration for state-licensed cannabis manufacturers, distributors and testing labs — annual fees set by tier
The Drug Enforcement Administration launched specialized DEA Form 225 registration forms for state-licensed medical cannabis manufacturers, distributors and analytical testing labs under the Schedule III framework, asking applicants to identify their state licenses and disclose criminal and disciplinary history. License-fee call-out — the federal registra…
Prohibition groups and pharma company ask D.C. Circuit to block Medicare hemp coverage plan
Smart Approaches to Marijuana, allied groups and MMJ International Holdings filed an appeals brief asking the D.C. Circuit to revive their challenge to the administration's plan giving eligible Medicare beneficiaries up to $500 a year toward low-THC hemp products; they argue the lower court wrongly denied them standing, while the government says the…
Delta-8's federal cutoff date remains unclear as FDA misses guidance deadline
Under the federal hemp law enacted last winter, products over 0.4 milligrams of total THC per container become controlled substances on December 11 — but delta-8 and other converted cannabinoids may fall under an earlier November 12 date that applies to lab-synthesized cannabinoids, and the FDA has not published the guidance that would settle which date g…
Treasury and IRS put cannabis tax guidance on the 2026–27 priority plan
The agencies' new Priority Guidance Plan for the fiscal year that began October 1 lists guidance under Section 280E among 121 priority projects. After the April move of FDA-approved products and state-licensed medical cannabis to Schedule III, 280E's bar on ordinary business deductions no longer reaches those operations, and the coming guidance…
DEA's updated Drugs of Abuse report reflects post-rescheduling landscape
The agency's 2026 edition of its 119-page reference report states that no deaths from marijuana overdose have been reported and, in a change from the 2024 edition, acknowledges that most U.S. states have legalized medical sales. The report also notes impairment risks and increased emergency-room visits involving edibles; a broader rescheduling procee…
Oregon hemp suppliers wind down operations ahead of December 11 federal THC limits
Oregon hemp retailers and suppliers say the federal hemp redefinition enacted last November is forcing closures ahead of its effective date, when finished hemp products containing more than 0.4 milligrams of total THC per container lose their federal hemp status. Oregon CBD — whose co-owner Seth Crawford says supplies the large majority of U.S. hemp seed…
Four senators ask DOJ to investigate Chinese criminal networks in cannabis and hemp markets
Sens. Tom Cotton (R-AR), Susan Collins (R-ME), Pete Ricketts (R-NE) and Ted Budd (R-NC) wrote to Attorney General Todd Blanche requesting an investigation into Chinese transnational criminal organizations' financing, land use and chemical imports in U.S. cannabis and hemp markets, writing that criminal networks are "exploiting vulnerabilities in…
Four Senators Ask DOJ to Investigate Chinese Role in U.S. Marijuana and Hemp Markets
Sens. Tom Cotton (R-AR), Ted Budd (R-NC), Pete Ricketts (R-NE) and Susan Collins (R-ME) sent a letter Wednesday to Attorney General Todd Blanche asking the Justice Department to investigate Chinese criminal organizations' involvement in U.S. marijuana and hemp markets, writing that such groups are "exploiting vulnerabilities in federal law"…
DEA judge pauses marijuana rescheduling hearing after opponents move to enter GAO report
DEA Chief Administrative Law Judge Derek Julius stayed the marijuana rescheduling hearing after three parties opposed to reform — the National Drug and Alcohol Association, DUID Victim Voices and Dr. Kenneth Finn — moved to enter a recent Government Accountability Office report into the record. The GAO report found the DEA "does not have any policies…
NIQ and MRI-Simmons data put intoxicating hemp beverages at a $300 million business
Research shared in a webinar by NIQ, MRI-Simmons and the Dry Atlas database values the intoxicating hemp beverage market at $300 million, with relaxation and stress relief the top reasons consumers cite for drinking the category. The figures land as the industry faces the delayed federal hemp ban, now set to take effect December 11 absent further congress…
Sen. Scott files amendment barring college-athlete NIL deals that promote alcohol or cannabis
Sen. Tim Scott (R-SC) filed an amendment to the pending college sports bill that would prohibit student-athlete name, image and likeness agreements promoting alcoholic beverages, marijuana, gambling, and tobacco or nicotine products. If the amendment is adopted, beverage brands and their retail partners using college-athlete endorsements would need to unw…
GAO finds “gaps” in DEA and FDA drug scheduling procedures as marijuana rescheduling review continues
A Government Accountability Office report published September 23 found that DEA has no policies or procedures for how its staff evaluate or schedule substances, that FDA lacks written procedures for the eight-factor scientific analyses behind scheduling recommendations, and that the FDA–NIH memorandum underpinning those reviews is more than 40 years old.…
New House bill would treat alcohol and cannabis as “high-risk” ad categories requiring platform verification
Rep. Valerie Foushee (D-NC) and Del. James Moylan (R-Guam) filed the SAFE Platforms Act (H.R. 10433), which would require digital platforms with 100,000+ monthly users or $25 million+ in annual revenue to run enhanced verification on advertisers in designated “high-risk” categories — including alcohol, cannabis, tobacco and other age-restricted consumable…
Two-thirds of Missouri cannabis operators skipped DEA registration under rescheduling — and none who applied are approved yet
After April’s federal rescheduling, DEA opened a registration portal tied to potential Section 280E tax relief, but roughly two-thirds of Missouri operators declined to apply, citing ownership- and employee-disclosure requirements, and none of the one-third that did apply had been approved as of Monday, according to the Missouri Cannabis Trade Association…
Fourth Circuit panel questions DEA’s Schedule I designation of hemp-derived HHC
At oral argument Friday, a Fourth Circuit panel that included Chief Judge Albert Diaz and Judge Toby Heytens appeared skeptical of the rationale the DEA used to designate hexahydrocannabinol (HHC), a psychoactive compound synthesized from hemp extracts, as a Schedule I substance. Hemp companies challenging the rule argue HHC qualifies as a legal hemp deri…
California cannabis chief: DEA has issued no rescheduling implementation guidance to states
California Department of Cannabis Control Director Clint Kellum told the state’s Cannabis Advisory Committee that regulators “have received no formal updates from DEA headquarters on implementation guidance” since the attorney general moved state-regulated medical marijuana to Schedule III in April — even as DEA conducts on-site inspections of registered…
Alabama health committee withdraws objection to federal marijuana rescheduling
Alabama's State Committee of Public Health voted unanimously Thursday to withdraw its May objection to the Justice Department's April order moving state-licensed medical cannabis to Schedule III. State Health Officer Dr. Scott Harris said the committee's original comments "weren't really about what we were trying to get at, which…
Bipartisan bill would shield insurers that cover state-licensed cannabis businesses
Reps. Nydia Velázquez (D-NY) and Warren Davidson (R-OH) introduced the Clarifying Law Around Insurance of Marijuana (CLAIM) Act, H.R. 10471, which would bar federal agencies from penalizing insurers, brokers and agents for serving state-licensed cannabis businesses and would prohibit terminating policies based solely on a cannabis connection. Velázquez sa…
U.S. Supreme Court asked to decide whether states may favor residents in cannabis licensing
Michigan entrepreneur Kenneth Gay and his Peridot Tree companies filed a petition asking the Supreme Court to decide whether the Dormant Commerce Clause bars state cannabis licensing schemes that favor in-state residents, after being denied licenses in Washington State and Sacramento. The Ninth Circuit upheld residency preferences, while the First and Sec…
Bipartisan group of senators reintroduces SAFE Banking Act
Sens. Jeff Merkley (D-OR) and Catherine Cortez Masto (D-NV), joined by cosponsors including Sens. Lisa Murkowski (R-AK), Steve Daines (R-MT), Kevin Cramer (R-ND) and Dan Sullivan (R-AK), reintroduced the Secure and Fair Enforcement (SAFE) Banking Act, which would allow banks to serve state-legal cannabis businesses.
Dispensary owner says DEA registration conditions require removing employees with felony drug convictions
Under the administration's move of state-licensed medical marijuana to Schedule III, businesses applying for federal protections must detail security, inventory, suppliers and personnel with access to controlled substances. Nicole Huff, CEO of a Mississippi dispensary, said DEA told her two employees with drug-related felony convictions must be remov…
Census Bureau: states collected $15.8 billion in marijuana tax revenue over five years
An updated U.S. Census Bureau report says states collected $3.55 billion in combined cannabis tax revenue between July 2025 and June 2026, and more than $15.8 billion since late 2021; California ($161 million) and Washington ($153.1 million) led collections in the second quarter of 2026, which totaled $987.5 million across 30 states and D.C.
Federal appeals court declines to halt marijuana rescheduling while challenges proceed
The U.S. Court of Appeals for the D.C. Circuit denied a motion by the National Drug and Alcohol Screening Association and MMJ International Holdings to pause the administration's marijuana rescheduling actions while their lawsuits proceed, writing that petitioners “have not satisfied the stringent requirements for a stay pending court review.” The co…
State Department warns against carrying marijuana, THC or CBD products across international borders
The State Department's Bureau of Consular Affairs said “just because a cannabis, THC, or CBD product is legal in your home state does not mean you can take it abroad,” naming CBD, edibles, vape cartridges, oils and concentrates, and noted that carrying such products internationally can lead to arrest regardless of U.S. legality.
Report: December 11 federal hemp ban would close 68% of U.S. hemp businesses
A new Whitney Economics analysis projects that 68.1% of U.S. hemp-related businesses would shut down if the federal hemp ban takes effect December 11 as scheduled, and that states would lose $1.2–$1.5 billion in annual tax revenue. Positions on the deadline remain split: Sen. Tim Sheehy (R-MT) said this week that "a blanket hemp ban would wipe out Am…
GAO: cannabis businesses still face limited banking access, elevated fees
A Government Accountability Office report requested by four Democratic senators found that about 1,000 banks and credit unions filed reports indicating they served cannabis businesses in 2024 — a small share of institutions nationwide — and that operators report account closures, months-long application processes, and elevated fees, in some cases exceedin…
Convenience-store industry asks Congress to regulate hemp THC products, not ban them
With the federal hemp THC ban now set to take effect December 11, the convenience-store industry is pressing Congress to replace prohibition with a regulatory framework that would keep the products on shelves for adults. Jon Taets, director of government relations at NACS, the convenience-store trade association, said the channel has "well-establishe…
CRS report: circuit split on cannabis licensing rules raises odds of Supreme Court review
A new Congressional Research Service analysis says conflicting appeals-court rulings on state residency requirements for cannabis business licenses "likely increases the odds" the Supreme Court eventually takes the issue. The First and Second Circuits have held such requirements violate the dormant Commerce Clause; the Ninth Circuit declined to…
House Republicans split over regulating or banning hemp THC products as delayed federal ban nears
With the federal hemp THC recriminalization now delayed from November 12 to December 11 under the bill President Trump signed last week, House Republicans are divided on what comes next. Rep. Beth Van Duyne (R-TX) is sponsoring a bill to tax and regulate hemp THC beverages like alcohol, Rep. Morgan Griffith (R-VA) filed legislation requiring third-party t…
Trump commutes two federal marijuana sentences as DEA rescheduling review advances
President Trump commuted the sentences of two people serving federal marijuana-distribution terms, while a DEA administrative judge prepares recommendations on moving cannabis to Schedule III — a determination the DEA administrator would then finalize. Attorney General Todd Blanche reclassified state-licensed medical cannabis and FDA-approved marijuana pr…
Three firms seek DEA authorization to import or manufacture cannabis for clinical research
Fisher Clinical Services (Pennsylvania), Irvine Labs (California) and PCI Pharma Services (Illinois) have applied to DEA to import or bulk-manufacture marijuana, extracts and THC for clinical trials and analytical research, with Federal Register notices scheduled for September 8 and a public comment and objection window to follow. The applications signal…
Trump signs funding bill delaying federal hemp THC ban to Dec. 11
President Trump on Wednesday signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, which funds the federal government through December 11 and moves the effective date of the federal ban on hemp-derived THC products from November 12 to that same December 11 date. The House passed the bill 370–48 on Tuesday following earlier Senate appro…